| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $300.8M | -10.0% |
| Cost of Revenue | $104.4M | -31.3% |
| Gross Profit | $196.4M | +7.7% |
| R&D Expense | $5.6M | -10.6% |
| SG&A Expense | $117.9M | -6.0% |
| Operating Income | -$20.8M | +69.3% |
| Pre-tax Income | -$5.9M | +79.9% |
| Income Tax | $3.6M | +892.3% |
| Net Income | -$9.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $21.7M | -21.4% |
| Inventory | $48.0M | -30.5% |
| Current Assets | $309.5M | -35.1% |
| Total Assets | $499.8M | -27.1% |
| Current Liabilities | $186.3M | +173.3% |
| Total Liabilities | $438.7M | -30.8% |
| Stockholders' Equity | $61.1M | +17.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.5M | +132.3% |
| Capital Expenditures | $303K | -59.9% |
| Investing Cash Flow | -$5.2M | +24.0% |
| Financing Cash Flow | -$174.9M | -10.5% |
| Free Cash Flow | $37.2M | +141.8% |
| +67.3% |
| EPS (Basic) | -$0.08 | +65.2% |
| EPS (Diluted) | -$0.16 | +55.6% |